A new study analyzing Medicaid databases from 2017 to 2021 has uncovered significant differences in how long-acting injectable (LAI) antipsychotic medications are prescribed to older adults across ...
June 4, 2009 — The latest results from the European First Episode Schizophrenia Trial (EUFEST) show that when it comes to improving cognition in patients with schizophrenia, there is little difference ...
Oral and parenteral antipsychotics showed similar outcomes in patients with schizophrenia experiencing agitation who presented to the emergency department (ED) with violent behavior, with no ...
—It’s widely used in practice, but the evidence supporting the safety and efficacy of polypharmacy in patients with schizophrenia spectrum and other disorders may be missing some pieces. Antipsychotic ...
When agitated dementia patients wander or shout through the night, families and caregivers understandably feel the need to treat this frightening and potentially dangerous behavior. Antipsychotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results